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ABSTRACT
Aims and objectives: The aim of the study was to
investigate and compare the financial impact of
Schmallenberg disease for different dairy production
types in the United Kingdom and France.
Materials and methods: Integrated production and
financial models for dairy cattle were developed and
applied to Schmallenberg virus (SBV) disease in a
British and French context. The five main production
systems that prevail in these two countries were
considered. Their respective gross margins measuring
the holding's profitability were calculated based on
public benchmarking, literature and expert opinion
data. A partial budget analysis was performed within
each production model to estimate the impact of SBV
in the systems modelled. Two disease scenarios were
simulated: low impact and high impact.
Results: The model gross margin obtained per cow
space and year ranged from £1014 to £1484 for the
UK and from £1037 to £1890 for France depending on
the production system considered. In the UK, the net
SBV disease costs in £/cow space/year for an average
dairy farm with 100 milking spaces were estimated
between £16.3 and £51.4 in the high-impact scenario
and between £8.2 and £25.9 in the low-impact
scenario. For France, the net SBV disease costs in
£/cow space/year ranged from £19.6 to £48.6 in the
high-impact scenario and £9.7 to £22.8 in the low-
impact scenario, respectively.
Conclusion: The study illustrates how the combination
of production and financial models allows assessing
disease impact taking into account differing management
and husbandry practices and associated price structures
in the dairy sector. It supports decision-making of
farmers and veterinarians who are considering disease
control measures as it provides an approach to estimate
baseline disease impact in common dairy production
systems in the UK and France.
INTRODUCTION
Each year millions of pounds are spent globally
on managing, preventing and researching
animal diseases. The current allocation of
money is largely based on biological processes
of transmission and infection, and the applica-
tion of biological knowledge to improve
disease management. There is limited refer-
ence to animal disease impacts, which should
be a fundamental aspect of prioritisation and
efficient resource allocation, be it at the farm,
national, international or global level. A princi-
pal reason for this is the lack of standardised,
rigorous methods for the financial impact
assessment of animal disease. At the farm level,
estimates on the financial impact of disease
provide important information for farm
decision-making. However, disease impact
studies at the farm level are highly variable due
to the complex nature of the effects a disease
exerts on production (Jericho 1974), augmen-
ted by numerous variables such as species,
breed or management.
Several authors elaborated a theoretical
methodological basis to estimate disease
impact. In the conceptual framework of
Mclnerney and others (1992), disease costs are
split into output losses following disease occur-
rence and expenditures made to treat disease
or prevent its occurrence. The economically
optimal level of disease costs is obtained using
a loss-expenditure frontier. This concept was
applied (Yalcin and others 1999, Chi and
others 2002, Alarcon and others 2013), at
times criticised (e.g. Tisdell 1995) and further
developed (e.g. Bennett and IJpelaar 2005,
Howe and others 2013) in a range of studies.
Commonly, disease impact models only look at
one or very few specified production types (e.
g. Alarcon and others 2013) and do not con-
sider finer details such as differences in pro-
duction type (e.g. dairy v beef), calving
patterns (e.g. block calving v all-year-round
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calving), reproductive services (e.g. use of bull, synchro-
nised insemination), feeding practices (e.g. intensive v
extensive) or breed and associated price structures (e.g.
different market prices due to product differentiations,
distinct geographic locations or selling times). Because
farm-specific factors influence disease impact and conse-
quently the most appropriate decision on cost-effective
disease management, disease cost estimates should reflect
the farm situation as closely as possible. One way of provid-
ing tailored information for farmers is to establish a farm-
level decision support system where the user can change
herd input data (e.g. herd size, cull rate) and disease-
specific assumptions (e.g. mortality rate due to disease).
Such disease control calculators for selected diseases were
developed and made available online by the University of
Reading (www.fhpmodels.reading.ac.uk) and the Royal
Veterinary College (http://www.bpex.org.uk/articles/
303060, Alarcon and others 2013) in the UK.
Schmallenberg virus (SBV) affects ruminants and
appears exclusively transmitted by insect vectors of the
Culicoides species group and vertically in utero (Beer and
others 2012, Garigliany and others 2012). Virus detection
in blood lasts up to 15 days after natural infection (Claine
and others 2013), and animals infected with SBV could
develop immunoprotection, which may prevent repeated
infection for at least two months (Wernike and others
2013). In ruminants, clinical signs are mainly associated
with reproductive disorders. Depending on the time of
infection, abortion, stillborn animals, premature deliver-
ies and various intrauterine congenital malformations
may occur (Conraths and others 2012, Steukers and
others 2012, Veldhuis and others 2014). SBV has been
detected in malformed fetuses, stillborn or newborn
calves born at term but with signs of neurological disor-
ders, such as blindness, deafness, recumbency, an inabil-
ity to suck and convulsions (Lievaart-Peterson and others
2012, Steukers and others 2012). Dystocia in cattle may
lead to negative impacts on animal welfare, culling and
cow deaths (European Food Safety Authority 2012).
In adult cows, the acute infection can result in transient
and non-specific symptoms, namely diarrhoea, inappe-
tence, fever and a reduction in milk yield, usually fol-
lowed by a full recovery (Hoffmann and others 2012,
Muskens and others 2012). While several studies were
published on the biological effects of the disease, to date
no scientific literature is available that estimates the finan-
cial impact of SBV at the farm level. Moreover, there is no
information on how different production systems in the
dairy sector are affected. Servicing or parturition in
certain periods of the year may coincide with increased
susceptibility of herds and/or other factors such as vector
presence that may impact on exposure to pathogens and
disease transmission (e.g. cows in autumn-calving herds
are expected to be in middle to late gestation during the
period of high-vector activity—a time when the fetus is
more susceptible to malformations and abortions). The
quantity of milk produced fluctuates during the year
depending on the production system, that is, it is more or
less constant for all-year-round-calving herds, whereas
highest production occurs in autumn for autumn-calving
herds and in spring/early summer for spring-calving
herds. Thus, effects on milk yield due to clinical disease
in adult animals during the period of high-vector activity
would be more prominent in spring-calving herds. Costs
and revenues are further influenced by seasonal changes
in prices for milk and concentrates. These effects are
schematically illustrated in online supplement 1. Finally,
management practices impact on the flexibility of
farmers’ decision-making. For example, a reproductive
disease in closed herds may result in higher numbers of
‘empty’ breeding animals, thus the herd fails to achieve
self-sustaining replacement rates, thereby causing sub-
optimal production. The same problem in an open herd
can be balanced by buying in replacement stock.
To examine disease effects in different production
systems and support decision-making on the farm, this
study presents integrated production and financial
models to estimate SBV disease costs in dairy cattle in
the UK and France. The objectives were (1) to develop
production models as a basis for financial analysis of
SBV in dairy farms, (2) to apply the models to estimate
the impact of SBV in the UK and France, and (3) to
investigate potential differences in model variables and
disease estimates between the two countries. This study
provides a first step towards the development of a farm
decision calculator for the control of SBV.
METHODOLOGY
Development of production models
Available benchmarking data and expert opinion was
used to identify the most common and representative
dairy cattle systems in the UK and France. In total, five
dairy production systems each were identified for the
UK and France (Table 1) based on relevant benchmark-
ing literature for the UK (Scottish Agricultural College
2010, Agro Business Consultants 2012, Nix 2013) and
France (Vignau-Loustau and Huyghe 2008). Literature
data were complemented by the authors’ knowledge and
experience of these systems and information shared by
expert colleagues.
For the UK, only Holstein farm models were developed
as these account for over 95 per cent of dairy production
in the UK (Agro Business Consultants 2012). Autumn
and all-year-round dairy systems were stratified into open
and closed herds, while spring-calving herds were
assumed to be mainly closed herds. In France, the differ-
ent dairy production systems are described primarily by
location and feeding type (Table 1). All French systems
apart from the Upland with grass Franche-Comté system
(UGFC) match the UK all-year-round open dairy system.
The UGFC system matches the UK dairy closed system
that uses all-year-round calving.
For the development of the production models, which
simulated one production cycle of one year, benchmark-
ing data from different independent sources based on
farm surveys and actual expenditures made by farmers
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were used for both the UK (Scottish Agricultural College
2010, Agro Business Consultants 2012, EBLEX 2012,
DairyCo 2013, Nix 2013) and France (Institut Elevage
Bovin lait 2013, Institut Elevage Bovin viande 2013,
Reuillon and others 2013, Institut Elevage Ovin lait 2012,
Institut Elevage Ovin viande 2013). Some of the available
benchmarking data needed to be complemented by other
sources, such as the authors’ expertise and published sta-
tistics on market prices. For example, expenditures in
France were available for the whole farm, but not
TABLE 1: Description of the dairy production types in the UK and France considered in this study
Country Farm types Description
The UK Spring-calving closed farms
(SC)
The majority of cows (80%) calve between February and May. Cows have a
lower than national average milk yield per year and a ’hardier constituency’
compared with very high-yielding herds. Feeding is predominantly grass with few
concentrates. Most herds are closed, i.e. replacement is done using own calves.
For this, all cows are mated with dairy bulls and most female heifers are used for
replacement
Autumn-calving open farms
(AOC)
The majority of cows (80%) calve between August and November. These farms
require an essential housing infrastructure and an increased amount of
concentrate. Cows have a higher than national average milk yield, and milk price
during the period of highest production is at the annual peak. Replacement 50%
from own heifers and 50% buying heifers from outside. The first two services a
cow receives are done using dairy bull semen; subsequent services using beef
bull semen (about 40% of calves born from beef bulls)
Autumn-calving closed farms
(ACC)
Similar to AOC, but with the difference that all replacements are bred and raised
in the same farm. Therefore, all cows are inseminated by dairy bulls and nearly
all heifers used for replacement. The 365-day calving rate in these farms is
assumed to be higher than in open herds.
All-year-round open farms
(AYOC)
Cows calve anytime during the year. Fertility is poorer than in the autumn- and
spring-calving systems and the replacement rate is consequently higher.
Replacement through own heifers (50% of replacements) and by purchasing
heifers from other farms. The first two services a cow receives are done using
dairy bull semen; subsequent services using beef bull semen (about 40% of
calves born are from beef bulls)
All-year-round closed farms
(AYCC)
Similar to AYOC, but with the difference that the replacement is done using only
own heifers. All cows are mated with dairy bulls and almost all heifers are used
for replacement. These farms are assumed to have better breeding performance
and therefore a higher calving rate than open farms
France Lowland with corn silage (LC) All-year-round calving; sometimes a calving peak may be seen in a proportion of
the herd. High milk yield and high cost of production. Corn silage as main forage,
normally all year long. Often zero-grazing system for cows in milk. A big part of
concentrates needed is soy bean meal or derivates (bought). Poor fertility and
high replacement rate. Replacement is mainly done using own heifers, but also
purchasing of heifers from other farms. Only cows with reproduction issues are
mated with beef artificial insemination (AI) (negligible)
Lowland with corn silage and
grass (LCG)
Similar to LC, but grass is used in spring and fall, and sometimes all summer
long (depending on area). It allows reducing the feed costs. Production remains
high
Upland with corn silage and
grass (UCG)
Relies predominantly on grass, even if corn silage is available at least for winter
(quantity available is limited). Production level is lower compared with LCG. Beef
AI can be used to increase the calf selling prices. Variable price of milk
compared with national level
Upland with grass Massif
Central (UGMC)
Located in mountains, centre of France. Mainly based on grass/hay. None or
limited use of grass or corn silage. Both Holstein (with low production) and
Montbéliarde breeds are used. Standard production (i.e. the same price applies
for milk here and in the lowlands) and high-quality production (Protected Area
Designation cheese, higher price of milk). Use of beef bull or bull AI is important
(often up to 50% of cows)
Upland with grass
Franche-Comté (UGFC)
Located in mountains, east of France. Mainly based on grass/hay. Silage
forbidden for cheese production. The production is highly specialised in
high-quality products (Protected Area Designation cheese Comté) with
Montbéliarde only and no use of beef bull crossing or AI. Higher price of milk
compared with national level
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disaggregated by the different classes of animals and thus
needed to be broken down using the authors’ professional
judgement.
Estimation of annual gross margins
The production models were used to estimate the
annual gross margins for the different production
systems (Eq. 1):
Gross margin ¼ Revenue Replacement costs
 Feed costs Veterinary costs
 other variable costs ð1Þ
A summary of calculations of revenues and costs is given
in Table 2. All input parameters associated with each
system are shown in online supplement 2. Detailed cal-
culations of revenues and costs are given in online sup-
plement 3.
The revenues, that is, the amount of money a farm
receives in exchange for its goods or outputs, included
the return from selling milk and animals. Milk price
took into account accuracy bonus, forecast bonus and
penalties when production drops below a certain thresh-
old. Animal outputs included calves for fattening, calves
for breeding, culled cows and, for the UK, non-calving
heifers. The latter represents those heifers that failed to
conceive, and that therefore have to be sold (block-
calving herds only). For France, non-calving heifers were
not considered because of the absence of block-calving
herds. Feed costs included the costs of concentrate,
forage, bulk feed and milk replacer for calves sold.
Forage costs were calculated differently for the UK and
France (Table 2). For the UK, forage costs were calcu-
lated my multiplying the ’forage costs per hectare’ by
the number of cows per hectare. For France, estimations
of forage costs for cows were based on the average daily
dry matter intake depending on the lactation stage, the
nature of the main forages used and the forage price. In
France, disposing costs are paid through a tax when
slaughtering animals and were therefore not included in
the French models. Other variable costs included the
costs of artificial insemination (AI), bedding, veterinary
and miscellaneous costs, as reported in benchmarking
data of both countries. Replacement costs accounted for
TABLE 2: Revenues and costs calculated in production models for dairy cattle in the UK and France (FR)
Revenues and costs Equations
Revenues
UK-FR: milk sold Total milk produced (l) x price of milk per litre (£)
UK-FR: dairy x dairy male calves (DDMCV) sold NDDMCV sold x DDMCV value (£)
UK-FR: dairy x beef male calves (DBMCV) sold NDBMCV sold x DBMCV value (£)
UK-FR: dairy x dairy female calves (DDFCV) sold NDDFCV sold x DDFCV value (£)
UK-FR: dairy x beef female calves (DBFCV) sold NDBFCV sold x DBFCV value (£)
UK: non-calving heifers sold NH not calving and sold x cull value cow (£)
UK-FR: revenues from cows culled NC culled x cull value cow (£)
Replacement costs
FR: costs of purchasing heifer calves NH bought x price of a replacement heifer calf (£)
UK: costs of purchasing in-calf heifers NH bought x price of an in-calf replacement heifer (£)
UK-FR: costs of raising own heifers NH that need to be raised to maintain the 100 milking spaces given the
production
parameters specified x costs of heifer rearing (£)
Feeding costs
UK-FR: costs of feed concentrate in cows Concentrates (kg) per litre of milk produced x price of dairy concentrate
per
tonne/1000 (£) x total milk produced (l)
UK: costs of forage in cows NC x [Forage costs (£) per hectare/(NC per hectare of forage)]
UK: costs of bulk feed NC x costs of bulk feed per cow (£)
FR: costs of forage in cows NC x forage costs per cow (£)
UK-FR: costs of milk replacer in calves sold NCV reared x price of milk per litre (£) x milk replacer (kg) per calf
Veterinary and disposal costs
UK-FR: veterinary costs in cows NC x total veterinary costs per cow (£)
UK: costs of disposing dead cows NC that die x disposal costs dead calf, cow or heifer (£)
UK: costs of disposing dead heifers NH that die x disposal costs dead calf, cow or heifer (£)
UK: costs of disposing dead calves NCV that die x disposal costs dead calf, cow or heifer (£)
Other variable costs
UK-FR: costs of artificial insemination NC x costs of artificial insemination per cow (£)
UK-FR: costs of bedding NC x costs of bedding per cow (£)
UK-FR: miscellaneous costs NC x miscellaneous costs per cow (£)
Input values are specific to each production system. Number (N) and quantities of animals/products indicated in the equations are obtained
from the production models
C, cow; CV, calf; H, heifer
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the costs of purchasing new heifers-in calf (open farms)
or raising own heifers (closed farms). For France,
heifers purchased were young animals (not in calf) in
accordance with the main practices observed. The
residual value of cows was accounted for as ’revenues
from cows culled’. The costs of raising own heifers were
calculated by estimating the number of heifers to be
raised in the herd (accounting for heifer mortality) and
multiplying this by the variable costs of heifer rearing
(VCHR) (Eq. 2):
VCHR ¼Heifer feeding costs (including forage)
þHeifer veterinary costsþHeifer bedding costs
þHeifermiscellaneous cost
þ Cost of artificial insemination ð2Þ
The heifer feeding costs were the average daily dry
matter intake of concentrates and forage multiplied by
the respective costs, for each rearing period from
weaning to the first calving.
Assessment of disease impact using partial
budget models
The scientific literature was screened to identify the bio-
logical effects of SBV in cattle, which included clinical
manifestations (diarrhoea, milk drop and fever) and
reproductive disorders (late abortion or malformations
and related dystocia). Assumptions were made on
general management practices and farmers’ reactions to
these biological effects (Box 1). In terms of disease
effects, it was assumed that milk drop would occur
during the duration of the clinical episode and that milk
production would return to normal after recovery. SBV
reproduction problems were assumed to occur in the
last trimester only (stillborn or malformed calves or
abortion) when cows are already dry. Due to the lack of
scientific evidence of early abortion or empty cows,
these effects were not included.
The production and gross margin models were run
with and without SBV disease parameters (Table 3), and
the differences obtained between a herd with SBV and a
herd without SBV were used to estimate the net value
using standard partial budget analysis (PBA), an eco-
nomic method used to calculate the extra cost or
benefit of a change (Eq. 3):
Net valuei ¼ (Costs savedi þ New revenuei)
 ðNew costsi þ Revenue foregoneiÞ ð3Þ
BOX 1: Assumptions made on general management practices and reactions to Schmallenberg virus (SBV)-related disorders
in the UK and France (FR) to estimate the financial impact of SBV
General management practices (without SBV)
UK-FR: 100 milk cow spaces used to full capacity. Lactation period will be extended for some of the cows not conceiving to cover empty
spaces.
UK: Farmers need to purchase extra in-calf heifers or use their own heifers to reach 80 calvings per 100 milk cow spaces because of low
calving rates. Assumption: fertility higher in closed than open herds.
FR: The high replacement rate of dairy farms in France leads to consider 85 calvings per year for 100 inseminated cows. In open herds, a
proportion of young heifers are purchased for replacement, whereas in closed herds replacement is done using own calves only.
UK-FR: All cows in closed herds inseminated with dairy bulls.
UK: 40 per cent of cows in open herds inseminated with beef bulls. Fifty per cent own stock replacement, 50 per cent purchase from
outside.
FR: 0 per cent (LC, UCG), 20 per cent (lowland with corn silage and grass) and 40 per cent (upland with grass Massif Central) of cows in
open herds inseminated with beef bulls. Low percentage: no replacement heifers are bought as not needed; high percentage: young heifers
can be purchased if needed. No purchasing of in calf heifers.
Farmers’ reaction to clinical disease
UK-FR: A very small proportion of SBV affected cows will receive treatment (anti-inflammatory) to suppress fever.
Reproductive SBV disorders and related management practices
UK-FR: In case of abortion, the cow will be culled. Open farms will buy in-calf cows to replace those who have aborted. Closed farms will
cull the cow and
▸ replace it the following year (the UK, block calving) with the exception of all-year-round farms
▸ replace it with older cows kept longer (FR and the UK, all-year-round calving)
UK-FR: When the number of heifers produced is not enough to achieve the required replacement rate,
▸ in closed herds, farmers will keep older cows longer; the farmer has no longer the possibility of disposing cows with poor milk yield and
therefore a reduction in milk production will occur;
▸ in open herds, in-calf heifers are bought and replacement heifers not sold (the UK).
FR-UK: In case of late abortion, the veterinarian will be called out if the fetus presents signs of malformation. Antibiotic treatment will be
applied to aborted cows.
FR-UK: When malformations lead to dystocia, the veterinarian will be called out. In few cases of dystocia, farmers will agree to conduct a
caesarean. Milk loss due to dystocia was considered negligible and was not included.
UK-FR: When there is no dystocia, the veterinarian will not be called out and there will not be any medical treatment.
FR-UK: The costs of culling a malformed calf are negligible, but not the disposal costs (the UK).
FR-UK: A small proportion of aborted fetuses and calves stillborn and malformed will be submitted for SBV testing.
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Net value (or net SBV disease costs) represents the
financial impact of SBV for a year cycle and a defined
disease scenario i. The individual partial budget items
can be found in the results tables and the associated cal-
culations in online supplement 3. For the PBAs, disease
parameters were introduced in the production models
and the differences between gross margin parameters of
disease and no disease situations were obtained. For
example, the number of ‘dairy x dairy male calves sold’
in a herd without SBV was higher than in an
SBV-affected herd as SBV infection can cause reproduct-
ive problems. Consequently, the difference between the
two was recorded as ’dairy x dairy male calves not sold’
under revenues foregone in the PBA.
Data on the within-herd SBV incidence, the incidence
of various disease effects (e.g. rate of diarrhoea, drop in
milk yield, fever) and the magnitude of those effects (e.
g. proportion of milk loss) are sparse. Consequently,
only two disease scenarios were considered:
1. Scenario 1: A high impact in a herd that is highly sus-
ceptible to disease, which may, for example, be a
management system where the susceptible gestation
period falls into a season of high-vector activity.
2. Scenario 2: A low impact in a herd that is less suscep-
tible to disease, which may, for example, be a man-
agement system in an area with low-vector density.
To complement the values derived from the scientific
literature, the input values for the model were discussed
and agreed on in the workshop described in the section
‘Software, input values, sensitivity analysis and valid-
ation’. For the most variable and uncertain parameters,
minimum, most likely and maximum values were agreed
upon (Table 3).
Software, input values, sensitivity analysis and validation
All models were built in Microsoft Excel. Apart from the
parameter values derived from published literature, a
workshop with 10 experts representing members of the
SBV surveillance team at the Animal Health and
Veterinary Laboratories Agency, industry representatives,
veterinary clinicians and academic researchers was held to
present and discuss the structure of the production
models, input variables and assumptions. Before the
meeting, experts were requested to complete a table with
their opinion on the values of specific disease parameters
(Table 3), and their ranges, for high- and low-impact scen-
arios. The different expert estimates obtained and their
averages were presented to the experts during the work-
shop for discussion. For the parameters with major differ-
ences and uncertainties, all workshop participants were
encouraged to explain why they disagreed and a discussion
was stimulated to get to an agreement on the most appro-
priate values. Further, the structure of the production
models, gross margin and partial budget analyses was pre-
sented and discussed until an agreement was reached. The
second workshop was held at the end of the study, where
the models developed and their results were presented.
Experts were asked for their opinion on the validity of the
results obtained. Similarly, animal health professionals in
France looked at the inputs and the assumptions made
and provided recommendations for improvement if
deemed necessary. Gross margin results were compared
with literature estimates for validation purposes.
Sensitivity analysis
The sensitivity analyses were done by varying simultan-
eously the two variables’ proportion of SBV abortions
(varied between 0 and 3.5 per cent in steps of 0.5 per
cent) and proportion of stillborn and malformed calves
(varied at values from 0 to 5 per cent in steps of 1
per cent). These variables were selected taking into
account the uncertainty attached to them and their hier-
archical position in the model. Uncertainty was deter-
mined considering the range of estimates collated from
the literature and experts, and the input from discussions
during the first expert workshop. In addition, the models
were run with all lowest and all highest values as defined
in Table 3 to estimate the range of disease impact.
RESULTS
Production models and gross margin analyses
Summarised results of the gross margin analyses are
shown in Figs 1 and 2, while the detailed structure and
results of the production models and gross margin ana-
lyses of non-SBV-infected farms are shown in online sup-
plements 2 and 3. The model gross margins obtained
for the UK’s spring-calving closed farms (SC), autumn-
calving open farms (AOC), autumn-calving closed farms
(ACC), all-year-round open farms (AYOC) and all-year-
round closed farms (AYCC) were £1014, £1471, £1484,
£1303 and £1326 per cow space per year, respectively
(Fig 1). Main differences observed between the model
gross margin and the industry gross margin were largely
caused by differences in the estimation of replacement
and feed costs (Fig 1). Overall model estimates were
higher than the estimates reported in the literature.
The model gross margins obtained for the French
lowland with corn silage (LC), lowland with corn silage
and grass (LCG), upland with corn silage and grass
(UCG), upland with grass Massif Central (UGMC) and
UGFC systems were £1431, £1428, £1291, £1037 and
£1890 per cow space and year, respectively. The model
gross margin estimations for the LC, LCG and UCG
systems showed differences of 3 per cent and 8 per cent,
respectively, to published gross margins (Fig 2). The dif-
ferences for the UGMC and UGFC systems were 13 per
cent and 21 per cent, respectively, due to lower oper-
ational costs in the present work compared with refer-
ences for these two upland systems (Fig 2).
Financial impact of SBV
Results of the SBV disease costs for dairy farms are
shown in Tables 4 and 5.
In the high-impact scenario in the UK, the net SBV
disease costs in £/cow space/year for an average dairy
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cattle farm were estimated at 38.8 in SC, 23.7 in AOC,
51.4 in ACC, 23.1 in AYOC and 16.3 in AYCC systems. In
the low-impact scenario in the UK, the net SBV disease
costs in £/cow space/year for an average dairy cattle
farm were estimated at 19.5 in SC, 11.9 in AOC, 25.9 in
ACC, 11.6 in AYOC and 8.2 in AYCC systems (Table 4).
In the high-impact scenario in France, the net SBV
disease costs in £/cow space/year were estimated at 19.9
in LC, 19.6 in LCG, 20.9 in UCG, 21.0 in UGMC and 48.6
in UGFC systems. In the low-impact scenario in France,
the net SBV disease costs in £/cow space/year were esti-
mated at 9.7 in LC, 9.6 in LCG, 10.3 in UCG, 10.5 in
UGMC and 22.8 in UGFC systems (Table 5). If LC, LCG,
UCG and UGMC were considered as closed, the net SBV
disease costs in £/cow space/year were estimated at 42.5,
50.5, 39.9 and 55.4 for the high-impact scenario and 20.7,
25.6, 19.7 and 28.0 for the low-impact scenario, respect-
ively. If UGFC was considered as open, the net total costs
£/cow space/year were estimated at 20.8 and 10.2 for the
high- and low-impact scenarios, respectively.
For all open systems (the UK and France), the main
costs of disease were associated with purchasing or
raising extra heifers for replacement (74–89 per cent of
the sum of costs). For closed farms in the UK, milk loss
due to culling cows with abortion represented the major
costs of disease (50–61 per cent of the sum of costs). For
the UGFC closed system in France, the replacement
costs and the revenues foregone from cows not culled
FIG 1: Dairy cattle production systems in the UK: break-down of revenues and variable costs in the models and gross margin
analyses in the literature. BCB12, Budgeting and Costing Book 2012; FMH2010, Farm Management Handbook 2010; JN13,
John Nix 2013; MB13, Milkbench Report 2013
FIG 2: Dairy cattle production systems in France: break-down of revenues and variable costs in the models and gross margin
analyses in the literature. LC, lowland with corn silage; LCG, lowland with corn silage and grass; UCG, upland with corn silage
and grass; UGFC, upland with grass Franche-Comté; UGMC, upland with grass Massif Central
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highly contributed to the sum of costs (32 and 27
per cent, respectively).
Sensitivity analyses performed for two of the most sensi-
tive and uncertain disease parameters expressed as net
SBV disease costs in £/cow space/year showed that an
increase in abortion rate influenced disease costs more
than a rise in number of calves stillborn or malformed
(see online supplement 4). For the UK, the net SBV
disease costs per cow space and year ranged from £0.1 to
£69.9 for SC, £0.1 to £44.1 for AOC, £0.1 to £91.6 for
ACC, £0.1 to £42.8 for AYOC and £0.1 to £41.0 for AYCC
farms. The ranges from the best case (using the
minimum values for all disease inputs as defined in
Table 3) to the worst case (using the maximum values for
all disease inputs as defined in Table 3) for the high-
impact scenario were £2.2 to £56 for SC, £2.4 to £42.5 for
AOC, £2.2 to £68.6 for ACC, £2.2 to £40.6 for AYOC and
£2 to £41.30 for AYCC farms. For the low-impact scenario,
the net costs per cow and year ranged from £0 to £19.5
for SC, £0 to £11.9 for AOC, £0 to £25.9 for ACC, £0 to
£11.6 for AYOC and £0 to £8.2 for AYCC farms.
For France, the net SBV disease costs per cow space
and year ranged from £0 to £35.2 for LC, £0 to £34.5 for
LCG, £0 to £36.8 for UCG, £0 to £38.4 for UGMC and
£0 to £86.6 for UGFC farms. The net costs ranges from
the best case to the worst case for the high-impact scen-
ario per cow space and year were between £1.9 and
£54.2 for LC, £2.1 and £53.2 for LCG, £2.0 and £55.9 for
UCG, £2.9 and £75.8 for UGMC, and £2.6 and £86.6 for
UGFC systems. For the low-impact scenario, the net costs
per cow and year ranged from £0.7 to £9.7 for LC, £0.7
to £9.7 for LCG, £0.7 to £10.3 for UCG, £0.7 to £10.5 for
UGMC and £0.7 to £22.8 for UGFC systems.
The impact of SBV on the farm profitability was
assessed by comparing the gross margins without SBV
and low- and high-impact SBV infection, respectively. In
the UK, the reduction in gross margin per cow space
and year was between 1.6 per cent (AYCC system) and
4.3 per cent (SC system) for the high-impact scenario,
and between 0.9 per cent (AOC system) and 1.3 per
cent (SC and AYOC systems) for the low-impact scen-
ario. In France, the reduction in gross margin per cow
space and year was between 1.4 per cent (open LC and
UCG) and 2.6 per cent (closed UGFC) for the high-
impact scenario and between 0.7 per cent (open LC
and LCG) and 1.2 per cent (closed UGFC) for the low-
impact scenario. Detailed results are given in online sup-
plement 5.
DISCUSSION
In the present study, farm-level models were developed
that combine herd dynamics and gross margin analysis of
different production systems as a basis for PBA to esti-
mate SBV disease costs in the UK and France. The pro-
duction models developed allow to account for financial
consequences that are related to specific management
practices that can be difficult to capture otherwise. The
results clearly illustrate that the disease impact differs sub-
stantially depending on the underlying production
system, based on closed or open farms, block calving and
all-year-round calving, heifer replacement management
and replacement rate, and various combinations thereof.
The production models proved particularly useful in esti-
mating the effects of disease parameters that have a
cascade effect. For example, an increase in abortions
means that fewer calves are born, which does not only
accrue a loss in the form of less calves sold, but also
reflects a cost due to more adult animals dying or being
culled because of the abortion. In the case of a closed
farm, this meant that either more calves needed to be
kept for replacement in the model or, if the calving rate
was not high enough, adult cattle earmarked for removal
from the herd due to production reasons were kept
longer. Consequently, block-calving closed herds were the
systems with higher disease impact due to limited flexibil-
ity in maintaining the same level of milk production and
the need to retain dairy heifer calves for the extra
replacement needed due to SBV (revenue foregone from
sales lost). On the other hand, major costs associated
with open farms accrued from purchasing or raising
heifers for replacement, which was almost double for
open farms compared with closed farms due to the high
market prices of replacement stock. Disease impact was
found to be generally higher for autumn-calving herds
due to higher replacement rates and milk price.
For France, the disease impact was also considerably
higher when closed herds were considered. This was
mainly due to the high replacement rate of French
herds (between 28 and 35 per cent compared with
the 20 and 25 per cent replacement rate of UK herds).
In disease situations that affect the number of calves
being raised, French closed farms cannot produce
enough heifers to achieve target replacement rates.
Consequently, they have to keep old cows that leads to
inefficient production and a higher disease impact in
such herds. While closed management does exist, it is
likely that such farms will switch to open management
to be able to use the existing milking spaces when facing
replacement difficulties. Certain situations, particularly
the scarcity of affordable replacement heifer or cows,
mimic the challenges closed herds face. This could, for
example, happen when demand for replacement
animals is high because of high milk prices and/or
there is limited supply of specific breeds (e.g. only few
farmers sell Montbéliarde animals). The LCG and
UGMC systems in France are open systems that are
heavily reliant on purchasing young heifers because they
commonly use beef bull or beef AI in their herds. The
LC and UCG systems may be open or closed, depending
on farmers’ behaviour.
Building on the gross margin models, costs saved, new
revenues, new costs and revenues foregone could be cal-
culated by comparing the values between farms mod-
elled to be healthy and those modelled to be diseased.
Importantly, the net value obtained in the PBA is
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equivalent to the difference of the gross margins with
and without disease. The partial budget approach helps
to understand what the magnitude of the additional
costs and benefit items are due to disease incursion and
which items most influence the impact and therefore
should be the focus of potential intervention measures.
The impact of SBV on the gross margin, on the other
hand, shows how profitability changes. This information
is also important for farmers as it may indicate sustain-
ability issues, reduction in capacity for investment and
determine the importance farmers will attribute to
disease. Consequently, both the PBA and gross margin
analysis provide critical information in relation to SBV
(or disease in general).
The partial budget could have been calculated without
the underlying production model by, for example, using
equations that take into account animal numbers, prices
and the cascade effects of disease parameters. However,
validation of such calculations would be difficult in the
absence of empirical data. In this study, the creation of
the production models allowed straightforward validation
of the costs, revenues and gross margins by comparing
them to published values on gross margins. For some pro-
duction systems, particularly in the UK models, some
model costs (e.g. replacement costs) were found to be
higher than those calculated by the industry, and there-
fore the overall gross margins were higher. One main
reason for this was that milk prices used were taken from
the DairyCo benchmarking data, which were consider-
ably higher than those used by other benchmarking
reports. The DairyCo milk prices were used because they
reflected the actual prices, whereas other references
used projected estimates. The second main reason was
that the calculations of replacement costs were similar to
the latter references, but dissimilar to DairyCo data.
Consequently, the UK models showed higher revenues
for milk than most references and lower replacement
costs than the DairyCo benchmarking report, which may
have led to a slight overestimation of SBV disease impact.
Nonetheless, the method and comparative approach
used represent a useful way to understand the possible
model deviations and their repercussion on the results.
The present models could also include situations that
were not accounted for in the example used. For
example, revenues foregone due to milk penalties asso-
ciated with low milk production did not apply because
milk drop and percentage of cows affected were too low
for that. However, such effects could be substantial in the
case of diseases that have a strong negative effect on milk
yield.
The SBV disease costs were presented for a low-impact
scenario and a high-impact scenario without providing
any information about the likelihood of a farm being in
the high-impact or low-impact category. The likelihood
of being in the SBV high- or low-impact category may be
different for the different production systems. For
example, all-year-round-calving farms are expected to
be less at risk of suffering from high impact due to
their flexibility on the time of calving. The French
systems, which are based on all-year-round calving, have
therefore greater scope to influence the risk of expos-
ure. However, only observational studies and/or epi-
demiological transmission models would allow
estimating the probability of disease on a farm with
some level of precision; this was not within the scope of
this study and remains open to further research.
One of the main limitations of this study was the lack of
data available in the literature on SBV disease effects,
which may be partly due to a lack of reporting and
the absence of incentives for reporting. Most of the pub-
lished scientific literature described the situation on
Schmallenberg-affected farms, but only in some excep-
tional cases compared them with non-affected farms or
previous years before SBV emergence. In consequence,
attribution of disease estimates was not possible from those
studies. Experimental studies or epidemiological studies
comparing affected and non-affected farms are needed in
order to obtain more accurate disease estimates. The
disease estimates used in this study were derived from
scientific publications when possible and complemented
by expert opinion consultation. Sensitivity analyses on
disease estimates were used to account for this uncertainty
and demonstrate the influence of the most uncertain
input values used.
Because of the biological and economic conse-
quences of SBV, there is a demand for effective animal
health interventions (Trickett 2013). Given the epi-
demiology of the virus and infection in wildlife, elimin-
ation of the virus from populations may prove
challenging and the focus therefore lies on interven-
tions to avoid the negative impact of disease. Vaccines
for SBV in ruminants have been developed in Europe
and licences have been approved in some EU countries
for marketing of the vaccine (Anonymous 2013a, b).
The purpose of SBV vaccines is to induce an immune
response that prevents the virus from reaching the
fetus. Farmers will need to make a judgement whether
the additional investment needed to protect their
herds or flocks is justified by the resulting loss avoid-
ance. Apart from vaccination, there are limited options
to control the disease effectively. Some authors sug-
gested measures to reduce exposure to the vector
through disruption of vector breeding sites, pesticide
use, housing and protection of ruminants by repellents
(Baylis and others 2010, British Cattle Veterinary
Association 2012). Additional measures could be a
breeding system that manages the timing of service or
insemination of animals depending on the season and
concentration of midges and thereby reduces exposure
to the virus in the critical period. However, such a strat-
egy may prove difficult where production and manage-
ment systems are targeted towards the seasonality of
grass growth and market demand.
The integrated production and partial budget models
could be used to assess the economic efficiency of
potential interventions at the farm level. There is scope
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to convert them into a farm-level decision tool where
veterinarians or farmers could enter farm-level-specific
data and thereby estimate disease impact and the net
value of potential interventions for their farms.
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